Neogen Corporation Stock Split Ratio
Neogen Corporation (NEOG) reported Stock Split Ratio of 133.00% for the 1-month period ending 2017-12-29, per its 10-K filed 2024-07-30.
Discontinued › Notes › Equity
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2024-07-30
- 2017-12-29: Stockholders' Equity Note, Stock Split, Conversion Ratio 133.00%; Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month 133.00%.
- 2013-10-31: Stockholders' Equity Note, Stock Split, Conversion Ratio 150.00%; Stockholders' Equity Note, Stock Split, Conversion Ratio 0 month 150.00%.
- 2013-10-30: Stockholders' Equity Note, Stock Split, Conversion Ratio 150.00%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio | Stockholders' Equity Note, Stock Split, Conversion Ratio 0 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month |
|---|---|---|---|
| 2017-12-29 | 133.00% 10-Q · filed 2019-03-29 | 133.00% 10-K · filed 2024-07-30 | |
| 2013-10-31 | 150.00% 10-Q · filed 2015-04-01 | 150.00% 10-Q · filed 2014-04-04 | |
| 2013-10-30 | 150.00% 10-K · filed 2016-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |